Compugen Ltd. To Present Cancer Immunotherapy Programs At Three International Cancer Conferences In March

Published: Feb 20, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Compugen Ltd. (NASDAQ: CGEN) today announced that its scientists are presenting at three international cancer conferences next month:

Cancer Progress, March 4-5, 2014 in New York, NY

Galit Rotman, PhD, Chief Scientist of Therapeutics, Compugen: Taking Immunotherapy Seriously: New Targets and Combinations

Help employers find you! Check out all the jobs and post your resume.

Back to news